glucosaminyl (N-acetyl) transferase 4
| GO Term | Evidence Code | PMID |
|---|---|---|
| neutrophil homeostasis | ||
| inter-male aggressive behavior | ||
| carbohydrate metabolic process | ||
| protein O-linked glycosylation | ||
| O-glycan processing |
| GO Term | Evidence Code | PMID |
|---|---|---|
| Golgi membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity | ||
| N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity | ||
| acetylglucosaminyltransferase activity |
| Gene Ontology |
|---|
| transferase activity |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|
| UDP-GlcNAc |
|
[alpha] |
|
[alpha] | |
| UDP-GlcNAc |
|
[alpha]-1-benzyl |
|
[alpha]-1-benzyl | |
| UDP-GlcNAc |
|
[alpha]-1-p-nitrophenyl |
|
[alpha]-1-p-nitrophenyl | |
| UDP-GlcNAc |
|
[alpha]-1-methylumbelliferyl |
|
[alpha]-1-methylumbelliferyl | |
| UDP-GlcNAc |
|
Ser/Thr |
|
Ser/Thr |
| Species | Protein | mRNA |
|---|---|---|
| Mus musculus | XP_138797 | XM_138797 |
| Rattus norvegicus | XP_226703 | XM_226703 |
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 2650 | WB:WBGene00001644 | ||
| 2651 | WB:WBGene00001644 | ||
| 9245 | WB:WBGene00001644 | ||
| 14537 | WB:WBGene00001644 | ||
| 14538 | WB:WBGene00001644 | ||
| 51301 | Xenbase:XB-GENE-1011770 | ||
| 64043 | WB:WBGene00001644 | ||
| 72077 | WB:WBGene00001644 | ||
| 140687 | WB:WBGene00001644 | ||
| 173109 | Xenbase:XB-GENE-1011770 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025